VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN

Nester, Carla M. and Bomback, Andrew S. and Ariceta, Gema and Delmas, Yahsou and Dixon, Bradley P. and Gale, Daniel P. and Greenbaum, Larry A. and Han, Seung Hyeok and Isbel, Nicole and Licht, Christoph and Mastrangelo, Antonio and Mizuno, Masashi and de Holanda, Maria Izabel Neves and Pickering, Matthew C. and Remuzzi, Giuseppe and Van De Kar, Nicole and Vivarelli, Marina and Walker, Patrick D. and Wallace, Dean and Zecher, Daniel and Li, Li and Wang, Zhongshen and Lazaro, Luis Lopez and Szamosi, Johan and Fakhouri, Fadi (2025) VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN. IMMUNOBIOLOGY, 230 (4): 153039. pp. 50-51. ISSN 0171-2985, 1878-3279

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Dr. Gernot Deinzer
Date Deposited: 18 Nov 2026 09:09
Last Modified: 18 Nov 2026 09:09
URI: https://pred.uni-regensburg.de/id/eprint/67760

Actions (login required)

View Item View Item